TITLE

Editorial: Immunosuppressive therapy in active chronic hepatitis

PUB. DATE
November 1973
SOURCE
British Medical Journal;11/24/1973, Vol. 4 Issue 5890, p441
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108907

 

Related Articles

  • Corticosteroid Therapy for Chronic Active Hepatitis. Berk, Paul D.; Jones, E. Anthony // Annals of Internal Medicine;Oct76, Vol. 85 Issue 4, p523 

    Editorial. Offers observation on published reports of studies on the use of corticosteroid for the treatment of chronic active hepatitis. Brief background on the term chronic active hepatitis; Views on the therapy; Effect of remission.

  • Development of Hodgkins Disease in the Course of Active Chronic Hepatitis Treated by Immunosuppressive Drugs. Pirotte, J. H. // American Journal of Gastroenterology;Sep1974, Vol. 62 Issue 3, p230 

    A case is described, believed to be the first, where Hodgkins disease developed in a patient treated for active chronic hepatitis by prolonged immunosuppressive therapy. Relations between autoimmune diseases and lymphomatosis are discussed. Oncogenic potentiality of immunosuppressive drugs,...

  • Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C. Horiike, Norio; Onji, Morikazu // Journal of Gastroenterology;2003, Vol. 38 Issue 3, p302 

    Editorial. Comments on the combination therapy with interferon-alpha and ribavirin as immunomodulators in patients with chronic hepatitis C virus. Effectiveness of interferon therapy for the treatment of chronic hepatitis C (CHC); Four possible mechanisms of rivirin in CHC; Role of ribavirin...

  • A new era of interferon treatment for chronic hepatitis C is coming. Kiyosawa, Kendo; Tanaka, Eiji; Kiyosawa, K; Tanaka, E // Journal of Gastroenterology;2000, Vol. 35 Issue 8, p652 

    Editorial. Deals with interferon therapy for chronic hepatitis C. Number of chronic hepatitis C patients in Japan treated with interferon; Recommendations for treatment of chronic hepatitis C; Considerations in interferon retreatment.

  • Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable. Lok, Anna S. F.; Ward, John W.; Perrillo, Robert P.; McMahon, Brian J.; Liang, T. Jake // Annals of Internal Medicine;5/15/2012, Vol. 156 Issue 10, p743 

    The article discusses the complications of immunosuppressive therapy. It states that the reactivation of hepatitis B virus (HBV) replication in patients with chronic or past HBV infection is the biggest complication of immunosuppressive therapy. It further states that the screening for HBV and a...

  • Chronic hepatitis in the 1980s. Hegarty, John; Williams, Roger // British Medical Journal (Clinical Research Edition);3/23/1985, Vol. 290 Issue 6472, p877 

    Investigates the occurrence of chronic hepatitis. Classification of the hepatitis into chronic persistent hepatitis and chronic active hepatitis; Characterization of chronic persistent hepatitis; Features of chronic active hepatitis.

  • Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B. Kiyosawa, Kendo; Tanaka, Eiji // Journal of Gastroenterology;2001, Vol. 36 Issue 2, p139 

    Editorial. Presents information on various therapies for patients with chronic hepatitis B virus infection. Mechanism of HBV replication and the site of action of interferon and lamivudine; Flares in hepatitis resulting in hepatic decompensation; Details of monotherapy with interferon or with...

  • Corticosteroid Therapy for Chronic Active Hepatitis.  // American Journal of Gastroenterology;Jul1984, Vol. 79 Issue 7, p573 

    Clarifies the indications and contraindications for corticosteroid therapy in chronic active hepatitis. Objective of steroids in chronic hepatitis; Therapy of patients who do not respond to corticosteroid therapy by clinicalm, biochemical, or histological criteria; Use of azathioprine or...

  • A Lethal Course of Chronic Hepatitis C, Glomerulonephritis, and Pulmonary Vasculitis Unresponsive to Interferon Treatment. Roithinger, Franz X.; Allinger, Stefan; Kirchgatterer, Andreas; Prischl, Friedrich; Balon, Reinhard; Haidenthaler, Alexander; Knoflach, Peter // American Journal of Gastroenterology;Jun1995, Vol. 90 Issue 6, p1006 

    Several extrahepatic syndromes have been associated with chronic hepatitis C virus infection. In our patient (a 57-yr-old woman without risk factors for hepatitis), chronic active hepatitis C was diagnosed serologically and histologically. Three months later, membranoproliferative...

  • Indication of prolonged interferon therapy for chronic hepatitis C. Okanoue, Takeshi; Itoh, Yoshito // Journal of Gastroenterology;2003, Vol. 38 Issue 2, p204 

    Editorial. Comments on prolonged interferon therapy for chronic hepatitis C. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on gastroenterology.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics